The combination drug Foracort Forte inhaler is mainly used to treat chronic obstructive pulmonary disease (COPD) and asthma. Its two main constituents are budesonide, an inhaled corticosteroid that lessens airway inflammation, and formoterol, a long-acting beta-agonist (LABA) that aids in relaxing airway muscles. This dual-action strategy effectively addresses underlying inflammation in addition to offering quick symptom relief, making it suitable for both acute and long-term care. Usually, the inhaler is given for routine use with the goal of enhancing respiratory health and lung function. To maximize benefits and reduce potential adverse effects, patients are recommended to utilize it continuously as prescribed by their healthcare physician. Consult a healthcare provider on a regular basis to assess treatment effectiveness and make any required adjustments.